SCHEMBL6868543

SCHEMBL6868543

CCCCCCCCC(CC)(CC(=O)O)C(=O)OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 7/20 0.44
TDP1 Q9NUW8 3/20 0.40
CYP4F2 P78329 1/20 0.40
CYP4A11 Q02928 1/20 0.40
FFAR1 O14842 1/20 0.40
CPT2 P23786 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38
PPARG P37231 3/20 0.38
PPARD Q03181 3/20 0.38
PPARA Q07869 3/20 0.38
TSHR P16473 2/20 0.38
GPR84 Q9NQS5 2/20 0.38
HDAC11 Q96DB2 2/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6863202 1.00 EPHX1 (0.44) EPHX1TDP1CYP4F2CYP4A11FFAR1
SCHEMBL6871631 1.00 EPHX1 (0.44) EPHX1TDP1CYP4F2CYP4A11FFAR1
SCHEMBL6873202 1.00 EPHX1 (0.44) EPHX1TDP1CYP4F2CYP4A11FFAR1
SCHEMBL6873371 1.00 EPHX1 (0.44) EPHX1TDP1CYP4F2CYP4A11FFAR1
SCHEMBL6869354 1.00 EPHX1 (0.44) EPHX1TDP1CYP4F2CYP4A11FFAR1
SCHEMBL6870912 1.00 EPHX1 (0.44) EPHX1TDP1CYP4F2CYP4A11FFAR1
SCHEMBL6873863 1.00 EPHX1 (0.44) EPHX1TDP1CYP4F2CYP4A11FFAR1
SCHEMBL6863982 0.98 EPHX1 (0.42) EPHX1TDP1CYP4F2CYP4A11FFAR1
SCHEMBL6870426 0.93 EPHX1 (0.39) EPHX1TDP1CYP4F2CYP4A11FFAR1
SCHEMBL8090529 0.91 EPHX1 (0.44) EPHX1TDP1FFAR1CPT2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165633-B1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE SPA (IT) 2004-07-14 EP disclosed
US-6716939-B2 COMPRISING TITANIUM, MAGNESIUM, HALOGEN AND AN ELECTRON DONOR COMPOUND SELECTED FROM ESTERS OF SUBSTITUTED SUCCINIC ACIDS BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2004-04-06 US disclosed
US-20020183575-A1 Components and catalysts for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2002-12-05 US disclosed
EP-1165633-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS Basell Technology Company B.V. (NL) 2002-01-02 EP disclosed
WO-2001057099-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL TECHNOLOGY COMPANY B.V. (NL) 2001-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183575-A1 Components and catalysts for the polymerization of olefins SCO2, ECI1, MT-CO2 EPHX1 2160/4885TDP1 2201/4885CYP4F2 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.